Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
Botulinum toxin type B (BoNT-B), known as Myobloc<sup>®</sup> in the United States and as Neurobloc<sup>®</sup> in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/15/2/147 |
| _version_ | 1827755335327154176 |
|---|---|
| author | Anna Campanati Federico Diotallevi Giulia Radi Emanuela Martina Barbara Marconi Ivan Bobyr Annamaria Offidani |
| author_facet | Anna Campanati Federico Diotallevi Giulia Radi Emanuela Martina Barbara Marconi Ivan Bobyr Annamaria Offidani |
| author_sort | Anna Campanati |
| collection | DOAJ |
| description | Botulinum toxin type B (BoNT-B), known as Myobloc<sup>®</sup> in the United States and as Neurobloc<sup>®</sup> in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as defining the dosing and application regiments of BoNT-B in the treatment of hyperhidrosis. Moreover, recent studies have been examining its safety profile, which may be different from those known about BoNT-A. The aim of this review is to provide information about what is currently known about BoNT-B in regards to the treatment of focal hyperhidrosis. |
| first_indexed | 2024-03-11T08:02:52Z |
| format | Article |
| id | doaj.art-70c8a2da46bd4217bfe33fc35937feb1 |
| institution | Directory Open Access Journal |
| issn | 2072-6651 |
| language | English |
| last_indexed | 2024-03-11T08:02:52Z |
| publishDate | 2023-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj.art-70c8a2da46bd4217bfe33fc35937feb12023-11-16T23:39:12ZengMDPI AGToxins2072-66512023-02-0115214710.3390/toxins15020147Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative ReviewAnna Campanati0Federico Diotallevi1Giulia Radi2Emanuela Martina3Barbara Marconi4Ivan Bobyr5Annamaria Offidani6Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, ItalyBotulinum toxin type B (BoNT-B), known as Myobloc<sup>®</sup> in the United States and as Neurobloc<sup>®</sup> in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as defining the dosing and application regiments of BoNT-B in the treatment of hyperhidrosis. Moreover, recent studies have been examining its safety profile, which may be different from those known about BoNT-A. The aim of this review is to provide information about what is currently known about BoNT-B in regards to the treatment of focal hyperhidrosis.https://www.mdpi.com/2072-6651/15/2/147botulinum toxin type Bfocal hyperhidrosispalmar hyperhidrosisaxillary hyperhidrosiscraniofacial hyperhidrosisplantar hyperhidrosis |
| spellingShingle | Anna Campanati Federico Diotallevi Giulia Radi Emanuela Martina Barbara Marconi Ivan Bobyr Annamaria Offidani Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review Toxins botulinum toxin type B focal hyperhidrosis palmar hyperhidrosis axillary hyperhidrosis craniofacial hyperhidrosis plantar hyperhidrosis |
| title | Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review |
| title_full | Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review |
| title_fullStr | Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review |
| title_full_unstemmed | Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review |
| title_short | Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review |
| title_sort | efficacy and safety of botulinum toxin b in focal hyperhidrosis a narrative review |
| topic | botulinum toxin type B focal hyperhidrosis palmar hyperhidrosis axillary hyperhidrosis craniofacial hyperhidrosis plantar hyperhidrosis |
| url | https://www.mdpi.com/2072-6651/15/2/147 |
| work_keys_str_mv | AT annacampanati efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT federicodiotallevi efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT giuliaradi efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT emanuelamartina efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT barbaramarconi efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT ivanbobyr efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview AT annamariaoffidani efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview |